Marketing Authorization Application for In-house Developed Insomnia Drug Lemborexant Accepted for Evaluation by European Medicines Agency (EMA)

TOKYO, July 17, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. announced today that the European Medicines Agency (EMA) has accepted for evaluation a marketing authorization application (MAA) for its in-house-discovered and developed orexin receptor antagonist lemborexant (generic name) for the treatment of adult patients with chronic insomnia.Lemborexant…

Hitachi and NVIDIA collaborate to advance HMAX and enable end-to-end autonomous operations through the integrated control of physical AI

Developing open and sovereign-enabled multi-agent orchestration technology to optimize the overall operations at industrial sites: Enabling autonomous operations by seamlessly connecting and controlling customer facilities, equipment, and systems—including those fromthird-party manufacturers.Connecting Hitachi’s social infrastructure intelligence platform ”IWIM” with NVIDIA Cosmos world foundation model to enable safe and secure control: Leveraging…

MHI Advances AI Infrastructure Commercialization with U.S. Deployment of 10MW-Class Chiller and MCP Development

TOKYO, July 17, 2026 - (JCN Newswire via SeaPRwire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) today announced deployment and strategic advancements in infrastructure technologies to meet the growing demands of high-performance computing environments, such as AI Factory.As AI Factory deployments accelerate, infrastructure requirements are rapidly expanding beyond conventional data centers…